CVE-2021-42118
Persistent Cross Site Scripting in Web Applications operating on Business-DNA Solutions GmbH’s TopEase® Platform Version <= 7.1.27 via the Structure Component allows an authenticated remote attacker with Object Modification privileges to inject…
Does this matter?
Lower severity and a low EPSS score (0.66%). Track it; it rarely justifies an emergency change on its own.
Description
Persistent Cross Site Scripting in Web Applications operating on Business-DNA Solutions GmbH’s TopEase® Platform Version <= 7.1.27 via the Structure Component allows an authenticated remote attacker with Object Modification privileges to inject arbitrary HTML and JavaScript code in an object attribute, which is then rendered in the Structure Component, to alter the intended functionality and steal cookies, the latter allowing for account takeover.
- CVSS 3.1
- 5.4 MEDIUMCVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
- EPSS
- 0.66% probability · 50th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-79
- Affected
- businessdnasolutions/topease
- Source
- vulnerability@ncsc.ch
References
- https://confluence.topease.ch/confluence/display/DOC/Release+NotesRelease Notes, Vendor Advisory
- https://confluence.topease.ch/confluence/display/DOC/Release+NotesRelease Notes, Vendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.